R. Raut, M. Kc, S. Rajbhandari, Murari Dhungana, Mukunda Sharma, S. Joshi, P. Bajracharya
{"title":"Cardiac Resynchronization Therapy- Single center experience in Nepal","authors":"R. Raut, M. Kc, S. Rajbhandari, Murari Dhungana, Mukunda Sharma, S. Joshi, P. Bajracharya","doi":"10.3126/njh.v16i2.26308","DOIUrl":null,"url":null,"abstract":"Background and Aims: Cardiac resynchronization therapy (CRT) has become an established treatment modality for patients with advanced heart failure. CRT abbreviates the dysynchronus heart failure mainly by correcting left ventricular dysynchrony. In the last three years, CRT has been regularly done in Shahid Gangalal National Heart Center(SGNHC) which has provided us the platform to report the outcome of CRT, for the first time in Nepal. The aim of this study is to review the recent clinical experience and outcome of CRT in our centre. \nMethods: All consecutive patients who underwent CRT at SGNHC from July, 2016 to July, 2019 were reviewed retrospectively. \nResults: Altogether 42 patients underwent CRT. Mean age was 65±11 years (range 43 to 84). Coronary sinus cannulation was successful in 41 patients. In one patient, LV lead delivery was unsuccessful. Thus, procedural success was obtained in 95% (40 out of 42) patients. LV lead dislodgement occurred in three patients (7%). Coronary sinus dissection occurred in two patients (5%). Biventricular (BiV) paced QRS was significantly narrower compared to baseline QRS (127ms Vs 162ms, p<0.01). During mean follow up of 12±10 months (range 1 to 30 months), there was significant improvement in the clinical outcomes: NYHA class (1.8 Vs 2.9, p<0.01), LVEF (22.3 Vs 27.5, p<0.01), left ventricle internal diameter in systole (LVIDs), (57 Vs 60.5 mm, p<0.01). The CRT responder rate was 86%. Super-responder was observed in 12% of patients. \nConclusion: In SGNHC, Cardiac resynchronization therapy is emerging as a routine treatment strategy with a reasonable efficacy and safety outcome.","PeriodicalId":52010,"journal":{"name":"Nepalese Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2019-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3126/njh.v16i2.26308","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepalese Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/njh.v16i2.26308","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Aims: Cardiac resynchronization therapy (CRT) has become an established treatment modality for patients with advanced heart failure. CRT abbreviates the dysynchronus heart failure mainly by correcting left ventricular dysynchrony. In the last three years, CRT has been regularly done in Shahid Gangalal National Heart Center(SGNHC) which has provided us the platform to report the outcome of CRT, for the first time in Nepal. The aim of this study is to review the recent clinical experience and outcome of CRT in our centre.
Methods: All consecutive patients who underwent CRT at SGNHC from July, 2016 to July, 2019 were reviewed retrospectively.
Results: Altogether 42 patients underwent CRT. Mean age was 65±11 years (range 43 to 84). Coronary sinus cannulation was successful in 41 patients. In one patient, LV lead delivery was unsuccessful. Thus, procedural success was obtained in 95% (40 out of 42) patients. LV lead dislodgement occurred in three patients (7%). Coronary sinus dissection occurred in two patients (5%). Biventricular (BiV) paced QRS was significantly narrower compared to baseline QRS (127ms Vs 162ms, p<0.01). During mean follow up of 12±10 months (range 1 to 30 months), there was significant improvement in the clinical outcomes: NYHA class (1.8 Vs 2.9, p<0.01), LVEF (22.3 Vs 27.5, p<0.01), left ventricle internal diameter in systole (LVIDs), (57 Vs 60.5 mm, p<0.01). The CRT responder rate was 86%. Super-responder was observed in 12% of patients.
Conclusion: In SGNHC, Cardiac resynchronization therapy is emerging as a routine treatment strategy with a reasonable efficacy and safety outcome.
背景和目的:心脏再同步治疗(CRT)已成为晚期心力衰竭患者的一种既定治疗模式。CRT主要通过纠正左心室不同步来缩短不同步性心力衰竭。在过去的三年里,Shahid Gangalal国家心脏中心(SGNHC)定期进行CRT,这为我们提供了报告CRT结果的平台,这在尼泊尔是第一次。本研究的目的是回顾我们中心最近CRT的临床经验和结果。方法:回顾性分析2016年7月至2019年7月在SGNHC接受CRT治疗的所有连续患者。结果:共有42例患者接受了CRT治疗。平均年龄为65±11岁(43至84岁)。41例患者冠状窦插管成功。在一名患者中,左心室导线输送不成功。因此,95%(42名患者中有40名)的患者获得了手术成功。三名患者(7%)发生左心室导线移位。两名患者(5%)发生冠状窦夹层。双心室(BiV)起搏QRS明显窄于基线QRS(127ms Vs 162ms,p<0.01)。在平均12±10个月(1至30个月)的随访中,临床结果有显著改善:NYHA分级(1.8 Vs 2.9,p<0.01)、LVEF(22.3 Vs 27.5,p<0.01),CRT应答率为86%。在12%的患者中观察到超级反应。结论:在SGNHC中,心脏再同步治疗正在成为一种常规治疗策略,具有合理的疗效和安全性。